Dry eye syndrome - Clinical trials 

Clinical trials for Dry eye syndrome

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Dry eye syndrome. For all clinical trials, go to clinical trials search

This list shows clinical trials for Dry eye syndrome

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Dry eye syndrome
Title Recruitment status Location
Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye Complaints Recruiting United Kingdom
An evaluation of the Ocular Surface Health in Subjects Using DuoTrav APS Eye Drops Solution Versus XALACOM® EYE Drops Solution - DuoTrav APS versus XALACOM® in OSDI Not Recruiting United Kingdom
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms Not recruiting United Kingdom
Efficacy of the Chronic Application of Tear Formulations Not recruiting United Kingdom
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers Not recruiting United Kingdom
TearLab Core Validation Study Not recruiting United Kingdom
A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial ofNOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion versus Vehiclein Patients with Moderate to Severe Dry Eye Syndrome - SICCANOVE Not Recruiting United Kingdom
A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion versus Vehicle in Patients with Moderate to Severe Dry Eye Syndrome - SICCANOVE Not Recruiting United Kingdom
An Evaluation of Patient Reported Outcomes and Ocular Surface Health in Patients Using DuoTrav APS Eye Drops Solution Versus XALACOM® Eye Drops Solution - DuoTrav APS versus XALACOM® in Patient Reported Outcomes and Ocular Surface Health Not Recruiting United Kingdom
A 3-month study of the efficacy and safety of SVS20 in patients with bilateral moderate dry eye syndrome: A prospective, double-masked, randomised, controlled, parallel-group, 3 arm, multicentre, phase III trial. Not recruiting United Kingdom